Athenex, Inc.
(NASDAQ : ATNX)

( )
ATNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.24%134.650.7%$1065.15m
BMYBristol-Myers Squibb Co.
-1.13%57.931.4%$763.21m
MRKMerck & Co., Inc.
0.00%84.900.7%$753.42m
PFEPfizer Inc.
0.00%37.280.9%$727.22m
ABBVAbbVie, Inc.
0.01%88.632.3%$702.21m
LLYEli Lilly & Co.
0.01%113.191.1%$394.23m
NVSNovartis AG
-0.17%89.890.2%$151.81m
AZNAstraZeneca Plc
0.97%47.911.2%$150.34m
RETAReata Pharmaceuticals, Inc.
-2.23%198.913.7%$144.23m
GSKGlaxoSmithKline Plc
0.41%44.280.2%$120.29m
NVONovo Nordisk A/S
-0.79%56.830.1%$78.10m
SNYSanofi
0.15%46.180.2%$64.64m
RARXRa Pharmaceuticals, Inc.
0.32%46.750.8%$39.41m
CNSTConstellation Pharmaceuticals, Inc.
-0.73%38.200.0%$30.53m
BHVNBiohaven Pharmaceutical Holding Co. Ltd.
4.20%51.080.0%$25.10m

Company Profile

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer.It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The Oncology Innovation Platform segment involves in discovery and development of cancer supportive therapies. The Global Supply Chain Platform segment consists of manufacturing and marketing of API, medical devices, and clinical products. The Commercial Platform segment engages in manufacturing and selling of commercial pharmaceutical products. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.